These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 16237395

  • 1. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.
    Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B, Anderson S, Doop M, Woodward N, Schoenberg E, Schmidt D, Baldwin R, Kessler R.
    Neuropsychopharmacology; 2006 May; 31(5):1016-26. PubMed ID: 16237395
    [Abstract] [Full Text] [Related]

  • 2. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.
    Cropley VL, Innis RB, Nathan PJ, Brown AK, Sangare JL, Lerner A, Ryu YH, Sprague KE, Pike VW, Fujita M.
    Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438
    [Abstract] [Full Text] [Related]

  • 3. Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.
    Riccardi P, Baldwin R, Salomon R, Anderson S, Ansari MS, Li R, Dawant B, Bauernfeind A, Schmidt D, Kessler R.
    Biol Psychiatry; 2008 Jan 15; 63(2):241-4. PubMed ID: 17586476
    [Abstract] [Full Text] [Related]

  • 4. Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study.
    Riccardi P, Zald D, Li R, Park S, Ansari MS, Dawant B, Anderson S, Woodward N, Schmidt D, Baldwin R, Kessler R.
    Am J Psychiatry; 2006 Sep 15; 163(9):1639-41. PubMed ID: 16946193
    [Abstract] [Full Text] [Related]

  • 5. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.
    Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M.
    Synapse; 2009 Jun 15; 63(6):447-61. PubMed ID: 19217025
    [Abstract] [Full Text] [Related]

  • 6. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET.
    Mukherjee J, Christian BT, Narayanan TK, Shi B, Collins D.
    Brain Res; 2005 Jan 25; 1032(1-2):77-84. PubMed ID: 15680944
    [Abstract] [Full Text] [Related]

  • 7. Sex differences in the relationship of regional dopamine release to affect and cognitive function in striatal and extrastriatal regions using positron emission tomography and [¹⁸F]fallypride.
    Riccardi P, Park S, Anderson S, Doop M, Ansari MS, Schmidt D, Baldwin R.
    Synapse; 2011 Feb 25; 65(2):99-102. PubMed ID: 20506565
    [Abstract] [Full Text] [Related]

  • 8. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy.
    Landvogt C, Buchholz HG, Bernedo V, Schreckenberger M, Werhahn KJ.
    Epilepsia; 2010 Sep 25; 51(9):1699-706. PubMed ID: 20384765
    [Abstract] [Full Text] [Related]

  • 9. Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride.
    Slifstein M, Kegeles LS, Xu X, Thompson JL, Urban N, Castrillon J, Hackett E, Bae SA, Laruelle M, Abi-Dargham A.
    Synapse; 2010 May 25; 64(5):350-62. PubMed ID: 20029833
    [Abstract] [Full Text] [Related]

  • 10. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
    Kegeles LS, Slifstein M, Frankle WG, Xu X, Hackett E, Bae SA, Gonzales R, Kim JH, Alvarez B, Gil R, Laruelle M, Abi-Dargham A.
    Neuropsychopharmacology; 2008 Dec 25; 33(13):3111-25. PubMed ID: 18418366
    [Abstract] [Full Text] [Related]

  • 11. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J, Christian BT, Dunigan KA, Shi B, Narayanan TK, Satter M, Mantil J.
    Synapse; 2002 Dec 01; 46(3):170-88. PubMed ID: 12325044
    [Abstract] [Full Text] [Related]

  • 12. Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.
    Kessler RM, Woodward ND, Riccardi P, Li R, Ansari MS, Anderson S, Dawant B, Zald D, Meltzer HY.
    Biol Psychiatry; 2009 Jun 15; 65(12):1024-31. PubMed ID: 19251247
    [Abstract] [Full Text] [Related]

  • 13. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Härtter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P.
    Neuropsychopharmacology; 2006 May 15; 31(5):1027-35. PubMed ID: 16237387
    [Abstract] [Full Text] [Related]

  • 14. Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol.
    Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY.
    Neuropsychopharmacology; 2005 Dec 15; 30(12):2283-9. PubMed ID: 16123775
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.
    Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G.
    Int J Neuropsychopharmacol; 2010 Aug 15; 13(7):951-60. PubMed ID: 20392299
    [Abstract] [Full Text] [Related]

  • 16. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum.
    Drevets WC, Price JC, Kupfer DJ, Kinahan PE, Lopresti B, Holt D, Mathis C.
    Neuropsychopharmacology; 1999 Dec 15; 21(6):694-709. PubMed ID: 10633475
    [Abstract] [Full Text] [Related]

  • 17. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.
    Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, Cooper T, Kegeles L, Zarahn E, Abi-Dargham A, Haber SN, Laruelle M.
    J Cereb Blood Flow Metab; 2003 Mar 15; 23(3):285-300. PubMed ID: 12621304
    [Abstract] [Full Text] [Related]

  • 18. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.
    Mukherjee J, Yang ZY, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen CT, Mintzer R, Cooper M.
    Nucl Med Biol; 1999 Jul 15; 26(5):519-27. PubMed ID: 10473190
    [Abstract] [Full Text] [Related]

  • 19. Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study.
    Chou YH, Halldin C, Farde L.
    Synapse; 2000 Nov 15; 38(2):138-43. PubMed ID: 11018787
    [Abstract] [Full Text] [Related]

  • 20. Nigrostriatal and Mesolimbic D2/3 Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors.
    Stark AJ, Smith CT, Lin YC, Petersen KJ, Trujillo P, van Wouwe NC, Kang H, Donahue MJ, Kessler RM, Zald DH, Claassen DO.
    J Neurosci; 2018 Mar 28; 38(13):3230-3239. PubMed ID: 29483278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.